MedPath

Evaluation of Implant Survival in Patients With a Pinnacle Ultamet Device in Conventional Total Hip Joint Replacement

Completed
Conditions
Arthropathy of Hip
Registration Number
NCT01684631
Lead Sponsor
DePuy International
Brief Summary

The objective is to evaluate the implant survival rate for patients implanted with a PINNACLE® ULTAMET™ Metal-on-Metal implant for conventional total hip arthroplasty for the treatment of a severe hip disease and true femoral cervical fracture.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
107
Inclusion Criteria
  • Patients susceptible to receive a PINNACLE® ULTAMET™ implant as per routine practice
Exclusion Criteria
  • Patient refusal to participate to the data collection
  • Pregnant woman
  • Patients age is less than 18 years old
  • The planned intervention is a revision of a previous intervention on the studied hip joint
  • Previous metal implant, except for pure titanium or titanium alloys
  • Exposure to cobalt and chromium that could influence serum metal ions levels
  • Planned bilateral intervention
  • Patient residing outside France
  • Patient not implanted with a Pinnacle(R) ULTAMET(TM)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Implant Survival Rateup to 5 years

Implant Survival Rate as the duration of PINNACLE® ULTAMET™ implantation for the follow-up duration, free of revision surgery, whatever the cause.

Secondary Outcome Measures
NameTimeMethod
Harris Hip Scorepre-operative, 1, 2, 3, 5 years

Measure of hip function using the Harris Hip Score

Trial Locations

Locations (6)

Clinique Herbert

🇫🇷

Aix-les-Bains, France

Clinique Bonnefon

🇫🇷

Ales, France

Centre Hospitalier Georges Renon

🇫🇷

Niort, France

Clinique Saint Hilaire

🇫🇷

Rouen, France

Clinique Pasteur

🇫🇷

Royan, France

Clinique Mutualiste Saint Etienne

🇫🇷

Saint Etienne, France

Clinique Herbert
🇫🇷Aix-les-Bains, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.